Malignant dermis tumor

Summary

Malignant dermis tumor (MONDO:0003363) is a cancer. A subtype of dermis tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant dermis tumor
Mondo ID	MONDO:0003363
DOID	DOID:5274
NCIT	C4574
SNOMED CT	255096006
UMLS	C0346811
MedGen	87564
GARD	0023477
Anatomy (UBERON)	UBERON:0002067
Is cancer (heuristic)	yes

Also known as: cancer of dermis · dermis cancer · malignant dermal neoplasm · malignant dermis neoplasm · malignant dermis tumor · malignant neoplasm of dermis · malignant neoplasm of the dermis · malignant tumor of dermis · malignant tumor of the dermis · malignant tumour of the dermis

Disease family

This is a subtype of dermis tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › skin neoplasm › dermis tumor › malignant dermis tumor

Related subtypes (7): cutaneous granular cell tumor, skin glomus tumor, leiomyoma cutis, cutaneous fibrous histiocytoma, juvenile hyaline fibromatosis, cutaneous mastocytosis, angioma serpiginosum

Subtypes (4): malignant cutaneous granular cell skin tumor, skin sarcoma, cutaneous neuroendocrine carcinoma, primary skin meningioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.